Documente Academic
Documente Profesional
Documente Cultură
COLLEGE OF NURSING
Handout Number 4
DRUG NOMENCLATURE / DOSAGE FORMS / DRUG INTERACTIONS
OBJECTIVES:
At the end of the discussion, the students will be able to:
• Understand the drug nomenclature
• Identify the different forms of drugs
• Comprehend how drug interact with body system
• Comprehend the different abbreviations commonly used in drug administration
I. DRUG NOMENCLATURE
A system of naming drugs based on its chemical component and molecular entities
by the official governing bodies
A trade name frequently appears with the sign ® at its upper right corner
which indicates that the name is registered and its production is restricted to that
pharmaceutical company as sole owner. So, trade name refers to a particular
company.
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 1
There is great debate about the use of non-proprietary vs trade name in the
prescription. However, drugs sold under non-proprietary names are usually
cheaper than those sold under trade names.
POWDERS- a preparation in the form of the fine particles either of a single drug or of
several drugs in combination. They are usually dispensed wrapped in a paper.
SUPPOSITORIES- dosage form that is shaped suitable for insertion into external
orifice of the body like the vagina, urethra or rectum. Once inserted, it either
dissolves slowly in the body fluids or melts at body temperature to release the
medicinal content.
Cocoa Butter- (vehicle or base) - waxy, solid at room or refrigerator
temperature but melts at body temperature.
SOLUTIONS- clear, liquid preparation, which contain one or more solvent water and
one or more dissolved component or solutes. Orally this is usually colored and
flavored.
Advantages: Easy to administer and doses can vary.
Types of Solution
1. Syrups- solutions that contain high concentration of dissolved sugar to mask
unpleasant taste of the drug.
2. Elixir- resolutions that contain a solvent mixture of alcohol and water as well
as other component. Usually employed as vehicle in dissolving substance,
which do not dissolve in water alone.
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 2
3. Tincture- solutions that contain alcohol as the primary solvent but which may
contain water as well.
4. Spirit- alcoholic solution of volatile drugs. Also called essence.
SUSPENSION- liquid dosage forms that contain solid drug particle that are
suspended in a suitable liquid medium. This should be shaken thoroughly prior to
administration.
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 3
CATEGORIES OF DRUG ORDERS
CATEGORY/DESCRIPTION EXAMPLE
Types:
I. GENERAL PURPOSE- Plastic/Glass
II. TUBERCULIN- 1 mL slender syringe
III. INSULIN SYRINGE- 1 mL capacity measured in units
IV. PRE-FILLED CARTRIDGES & SYRINGE-needles are permanently attached
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 4
ABBREVIATIONS COMMONLY FOUND IN DRUG ORDERS
DRUG MEASUREMENTS AND DRUG FORMS
TIMES OF ADMINISTRATION
Abbreviation Meaning Abbreviation Meaning
AC, ac Before meals qh Every hour
ad lib As desired Q.i.d., q.i.d. Four times a day
B.i.d., b.i.d. Twice a day q.o.d. Every other day
C With s Without
Hs Hours of sleep SOS Once if
necessary, if
there is a need
Noct At night Stat Immediately
NPO Nothing per orem T.i.d., t.i.d. Three times a
(mouth) day
PC, pc After meals
PRN, p.r.n. Whenever necessary, as
needed
Q Every
QAM Every morning
qd, od Every day, once a day
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 5
ABBREVIATIONS OF SOLUTIONS
Intravenous Solution Abbreviation
5% Dextrose in Water D5W, 5% D/W
10% Dextrose in Water D10W, 10% D/W
0.9 Sodium Chloride 0.9 NaCl
Normal Saline Solution NSS
0.45% Sodium Chloride, ½ NSS 0.45 NaCl, ½ NSS
5% Dextrose in 0.95 sodium chloride D5NSS, 5% D/NSS
5% Dextrose in Lactated Ringers Solution D5LRS
Balance Multiple Replacement Solution with 5% D5NM
Dextrose or Eurosol-R in D5 Water
Balance Multiple Maintenance Solution with 5% D5IMB
Dextrose or Eurosol-M in D5 Water
Balance Multiple Replacement Solution with 5% D5NR
Dextrose or Normosol-R in D5 Water
Lactated Ringers Solution Plain LRS, PLRS
Balance Multiple Maintenance Solution with 5% D5MK
Dextrose or Eurosol-MK in D5 Water with Light
Potassium
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 6
B. Drug Interaction and Pharmacokinetics
1. Altered Absorption – drugs may inhibit absorption of other drugs across
biologic membranes by:
a. Change in the gastric emptying time
b. Change in the gastric pH
2. Altered Distribution – administration of two or more drugs that are highly
protein bound.
3. Altered Metabolism – induction or competition for metabolizing enzymes.
4. Altered Excretion – drugs may act on the kidneys to reduce excretion of
specific agents.
2. Distribution
- decreased BP effects blood flow to tissues, liver and brain and kidneys.
- 65 to 75% of total body weight is comprised of water hence, a relatively
“larger” dose is needed to achieve intended drug effect/compared to
adults whose body water is relatively decreased in relation to TBW.
- Decreased plasma CHON binding sites (longer half-life).
- Blood-brain barrier is relatively developed.
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 7
3. Metabolism
- immature liver, decreased activity of liver enzymes, half-life may be
prolonged (first pass system is less effective).
4. Excretion
- immature kidneys, until after the first year of life.
- decreased blood flow to kidneys; GFR is 30-40% of adults rate (longer
half-life and possible toxicity).
B. Pharmacodynamics
- immature organs affect drug action and drug dosage frequently needs to
be adjusted.
- rapidly developing tissues of infants and small kids can be more sensitive
to certain drugs.
e.g.: tetracycline can cause permanent discoloration of the teeth if given
during the last trimester and early childhood.
- Corticosteroid therapy can result in suppression of growth.
NCM 0106| Pharmacology|| HO4: Drug Nomenclature, Forms and Interactions| Page | 8